Biolife Solutions (BLFS) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $79.0 million.
- Biolife Solutions' Cash & Current Investments rose 13094.07% to $79.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.0 million, marking a year-over-year increase of 13094.07%. This contributed to the annual value of $104.6 million for FY2024, which is 13670.11% up from last year.
- Per Biolife Solutions' latest filing, its Cash & Current Investments stood at $79.0 million for Q3 2025, which was up 13094.07% from $81.8 million recorded in Q2 2025.
- Over the past 5 years, Biolife Solutions' Cash & Current Investments peaked at $104.6 million during Q4 2024, and registered a low of $34.1 million during Q2 2024.
- In the last 5 years, Biolife Solutions' Cash & Current Investments had a median value of $61.6 million in 2022 and averaged $62.9 million.
- As far as peak fluctuations go, Biolife Solutions' Cash & Current Investments skyrocketed by 129164.06% in 2021, and later plummeted by 3899.4% in 2022.
- Quarter analysis of 5 years shows Biolife Solutions' Cash & Current Investments stood at $69.9 million in 2021, then dropped by 10.26% to $62.7 million in 2022, then dropped by 29.53% to $44.2 million in 2023, then soared by 136.7% to $104.6 million in 2024, then decreased by 24.51% to $79.0 million in 2025.
- Its last three reported values are $79.0 million in Q3 2025, $81.8 million for Q2 2025, and $88.6 million during Q1 2025.